The absence of ALKBH3 allows cancer cells to grow more freely and is an indicator of malignancy for this type of tumors. The study, published in Blood, has the participation of IDIBELL, ICO and HUB, among others.
ALKBH3 biomarker helps predict Hodgkin lymphoma aggressiveness Read More »
Cisplatin induces senescence of peripheral neurons through overexpression of the p21 protein, which would explain the neuropathy
Identified the cellular process by which Cisplatin chemotherapy causes neuronal damage Read More »
When a cancer is diagnosed, the patient asked many questions: about the treatment, his new daily rutine, his new life… And also about a new way of eating. A good diet is essential to guarantee a good nutritional state and to tolerate cancer treatments. Moreover, it is known that side effects contribute to malnutrition in
erón’s project proposes to use the nematode C. elegans to introduce into its genome cancer mutations from patients. Thus, have a low-cost animal model to obtain functional information on these mutations and explore therapeutic possibilities by testing drugs in these avatar worms with patient mutations.
The AECC finances the implantation of a new cancer model in C. elegans Read More »
An international consortium with the participation of IDIBELL has identified alterations in interferon and the proteins of its signaling pathway, the first line of defense against pathogens, as predictive markers of severity in individuals with no medical history.
Interferon, the key to many of the worst cases of COVID-19 in young people Read More »
A trip into the musical brain: this was the artistic and scientific experience that the 2020 edition of the Sónar+D Festival offered this past Saturday, within a special program that combined the streaming and face-to-face formats from the Center for Contemporary Culture of Barcelona. Dr. Antoni Rodríguez Fornells, a researcher at IDIBELL, ICREA and the
IDIBELL participates in Sónar+D to take a trip to the musical brain Read More »
Jordi Guiu joins to IDIBELL as group leader and opens the Cell Plasticity and Regeneration group of the Regenerative Medicine Program
Jordi Guiu, the new group leader of the Regenerative Medicine Program Read More »
Six scientists from IDIBELL have received training to perform a scientific monologue in live and to produce an informative video on YouTube.
Stand-up science has started preparing IDIBELL scientists to become a science YouTubers Read More »
The group led by Dr. Óscar Martínez-Tirado will receive 180,000 euros in two years to develop a new therapy for Ewing’s sarcoma.
IDIBELL’s sarcoma research group will receive one of the new grants of AECC Innova Read More »
The goal is to train 15 young researchers in the understanding of metastatic processes and their evolution, with the aim to identify therapeutic solutions. The Evomet consortium is formed by 13 institutions, which include several of the best academic, clinical and industrial centres working in cancer research and metastasis research in Europe. Awarded in the
